Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]

Affiliations

¹ Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, China.
² Gastrointestinal Surgery Center, the First Affiliated Hospital of Sun Yat-Sen University, China.
³ Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, China. Electronic address: yangak@sysucc.org.cn.

Published Erratum

Weichao Chen et al. Eur J Pharmacol. 2019.

. 2019 Mar 15:847:158.

doi: 10.1016/j.ejphar.2018.11.042. Epub 2018 Dec 7.

¹ Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, China.
² Gastrointestinal Surgery Center, the First Affiliated Hospital of Sun Yat-Sen University, China.
³ Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, China. Electronic address: yangak@sysucc.org.cn.

No abstract available

Erratum for

Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway.
Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A. Chen W, et al. Eur J Pharmacol. 2018 Nov 15;839:33-39. doi: 10.1016/j.ejphar.2018.09.020. Epub 2018 Sep 19. Eur J Pharmacol. 2018. PMID: 30244004